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It is with great pleasure that I have accepted the challenge of reviewing and summa-
rizing the articles published in Molecules through 2019 and 2020 on radioactive molecules.
This is a very interesting subject but also a challenging one, because research on radioactive
molecules is a very versatile area. The progress in one area often is dependent on the further
development and progression in others. For example the invention and commercializing of
the SPECT, SPECT/CT, PET and PET/CT scanners, the invention of new useful tracer like
[18F]FDG and [68Ga]Ga-PSMA as well as when the generators and cyclotrons were made
commercially available, all are of inventions which have had a big impact on the entire
area, this reflected on publications and publications rate.
A search in Molecules from 2019 to 2020 using the keyword “radio *” resulted in
181. A review of the 181 publications revealed that 109 had radioactive molecules in focus.
Radioactive molecules are mainly used in medicine for diagnosing or treating of diseases.
Six of the 109 publications had other focuses, e.g., the use of radiation for sterilization
or preventing and/or cleaning up radioactive contamination. The further focus of the
review will be on the 103 publications which, in some way, use or aim at using radioactive
molecules for medical purpose. Of these 103 publications, 21 were reviews. To illustrate
the diversity of the articles, an examination was made of the title, keywords, abstract and
in a few cases, also, the content of the paper to find out whether the publications dealt
with, diagnostics, therapy, synthesis and/or nuclide preparation. In addition, the nuclides
referred to in the papers are also listed (Table 1, An overview of what topics and nuclides
the articles deal with).
Table 1. An overview of what topics and nuclides the articles deal with.
Diagnostic Therapy Synthesis NuclidePreparation Ref.
70.9% 23.3% 39.8% 8.7%
18F 31 19 [1–6]
99mTc 15 13 [1,6,7]
68Ga 12 9 1 [1,5,6,8,9]
11C 6 5 [2,4,6]
125I 5 2 [6,10]
89Zr 5 3 2 [2,6]
15O 4 [2]
111In 3 [1]
64Cu 2 3 [2,6]
45Ti 1 1 1
44Sc 1 2 [8]
55Co 1
Molecules 2021, 26, 529. https://doi.org/10.3390/molecules26030529 https://www.mdpi.com/journal/molecules
Molecules 2021, 26, 529 2 of 3
Table 1. Cont.
Diagnostic Therapy Synthesis NuclidePreparation Ref.
123I 2 [10]
3H 1
177Lu 7 6 1 [1,6,8]











None of the isotopes applied in the 103 above mentioned articles are naturally occur-
ring so the first step would be to produce them, this is reflected in some of the publications
as they have their roots in nuclear chemistry i.e., how to produce the isotopes. Other arti-
cles are in the field of medicinal chemistry, they deal with purification of the isotopes and
incorporation of the isotopes into molecules of biological interest. It is common synthetic
reaction and analytic procedure which is applied. They however have to be fast due to the
short half-life of the isotope. Moreover, the syntheses must be suitable for automatization
because protection to the staff against continuous exposer to radioactivity is required
hence the need for automatization of the synthesis. Radioactive molecules are normally
developed with the aim in mind of diagnosing diseases and/or to treat them. Some of
the 103 articles describe how to employ animal or human biology and pharmaceutical
chemistry to test the radioactive tracers in biologically relevant settings. However, looking
at the articles published in molecules one quite often see that articles are a nice mixture of
some or all of the above-mentioned chemical disciplines, nuclear-, medicinal-, synthetic-,
analytical, animal-, human- and/or pharmaceutical chemistry.
The articles often aimed at exploring diagnosing or treating a specific disease, this
were also registered. Of the 103 articles, 39 where concerning cancer [1] (eight articles on
prostate [6], four on brain tumor/glioblastoma [2], three on ovaria cancer, three on neuroen-
docrine (somatostatin), two on, each of, breast cancer, bone cancer or colon rectal carcinoma
and one on gastric cancer, lung cancer [10], solid tumor or multiple myeloma). There were
18 articles which deals with different kind of brain disorder (six articles on Alzheimer’s
disease [3,4], three on Parkinson [4], three on neurological disorders and one on, each
of, serotonin transporters, synaptic vesicle protein, phosphodiesterase, mood disorder or
opioid receptor). There were seven articles about inflammation/infection (three articles
on infection, two on osteomyelitis [8] and one on inflammation or on CXCR4 expression).
Finally, there were nine articles on other diseases (two articles on cardiovascular and one
on, each of, hyperlipidemia, peptide transporter, atherosclerotic plaques, sentinel node,
invasive fungal, renal protection or vitamin E’s bio-distributions).
The clinical use as well as the research interest in the area of radioactive molecules
have grown intensely though-out many years. This tendency is also seen in Molecules
where the number of papers published in 2019–2020 is about the same as the numbers
published in the previous 19 years (2000–2018).
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I was asked to select ten papers which I find extra ordinarily interesting. It has not
been easy because I had to reduce my originally shortlist from 37. To reduce further,
I have tried to choose papers that support what I have tried to say in my mini-review on
radioactive molecules that was published in Molecules in 2019 and 2020, namely that the
research area “radioactive molecules” is a very versatile one.
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